BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28438992)

  • 21. Prosaposin is a regulator of progranulin levels and oligomerization.
    Nicholson AM; Finch NA; Almeida M; Perkerson RB; van Blitterswijk M; Wojtas A; Cenik B; Rotondo S; Inskeep V; Almasy L; Dyer T; Peralta J; Jun G; Wood AR; Frayling TM; Fuchsberger C; Fowler S; Teslovich TM; Manning AK; Kumar S; Curran J; Lehman D; Abecasis G; Duggirala R; Pottier C; Zahir HA; Crook JE; Karydas A; Mitic L; Sun Y; Dickson DW; Bu G; Herz J; Yu G; Miller BL; Ferguson S; Petersen RC; Graff-Radford N; Blangero J; Rademakers R
    Nat Commun; 2016 Jun; 7():11992. PubMed ID: 27356620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.
    Minami SS; Min SW; Krabbe G; Wang C; Zhou Y; Asgarov R; Li Y; Martens LH; Elia LP; Ward ME; Mucke L; Farese RV; Gan L
    Nat Med; 2014 Oct; 20(10):1157-64. PubMed ID: 25261995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.
    Takahashi H; Klein ZA; Bhagat SM; Kaufman AC; Kostylev MA; Ikezu T; Strittmatter SM;
    Acta Neuropathol; 2017 May; 133(5):785-807. PubMed ID: 28070672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptic dysfunction in progranulin-deficient mice.
    Petkau TL; Neal SJ; Milnerwood A; Mew A; Hill AM; Orban P; Gregg J; Lu G; Feldman HH; Mackenzie IR; Raymond LA; Leavitt BR
    Neurobiol Dis; 2012 Feb; 45(2):711-22. PubMed ID: 22062772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12).
    Suh HS; Choi N; Tarassishin L; Lee SC
    PLoS One; 2012; 7(4):e35115. PubMed ID: 22509390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations.
    Zhou X; Sun L; Bracko O; Choi JW; Jia Y; Nana AL; Brady OA; Hernandez JCC; Nishimura N; Seeley WW; Hu F
    Nat Commun; 2017 May; 8():15277. PubMed ID: 28541286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin.
    Hu F; Padukkavidana T; Vægter CB; Brady OA; Zheng Y; Mackenzie IR; Feldman HH; Nykjaer A; Strittmatter SM
    Neuron; 2010 Nov; 68(4):654-67. PubMed ID: 21092856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
    Arrant AE; Roth JR; Boyle NR; Kashyap SN; Hoffmann MQ; Murchison CF; Ramos EM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Roberson ED
    Acta Neuropathol Commun; 2019 Dec; 7(1):218. PubMed ID: 31870439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency.
    Lee WC; Almeida S; Prudencio M; Caulfield TR; Zhang YJ; Tay WM; Bauer PO; Chew J; Sasaguri H; Jansen-West KR; Gendron TF; Stetler CT; Finch N; Mackenzie IR; Rademakers R; Gao FB; Petrucelli L
    Hum Mol Genet; 2014 Mar; 23(6):1467-78. PubMed ID: 24163244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia.
    Rosenthal ZC; Fass DM; Payne NC; She A; Patnaik D; Hennig KM; Tesla R; Werthmann GC; Guhl C; Reis SA; Wang X; Chen Y; Placzek M; Williams NS; Hooker J; Herz J; Mazitschek R; Haggarty SJ
    Sci Rep; 2024 Apr; 14(1):9064. PubMed ID: 38643236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.
    Janssens J; Philtjens S; Kleinberger G; Van Mossevelde S; van der Zee J; Cacace R; Engelborghs S; Sieben A; Banzhaf-Strathmann J; Dillen L; Merlin C; Cuijt I; Robberecht C; Schmid B; Santens P; Ivanoiu A; Vandenbulcke M; Vandenberghe R; Cras P; De Deyn PP; Martin JJ; Maudsley S; Haass C; Cruts M; Van Broeckhoven C;
    Acta Neuropathol Commun; 2015 Nov; 3():68. PubMed ID: 26555887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia.
    Raitano S; Ordovàs L; De Muynck L; Guo W; Espuny-Camacho I; Geraerts M; Khurana S; Vanuytsel K; Tóth BI; Voets T; Vandenberghe R; Cathomen T; Van Den Bosch L; Vanderhaeghen P; Van Damme P; Verfaillie CM
    Stem Cell Reports; 2015 Jan; 4(1):16-24. PubMed ID: 25556567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
    Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
    Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons.
    Hasan S; Fernandopulle MS; Humble SW; Frankenfield AM; Li H; Prestil R; Johnson KR; Ryan BJ; Wade-Martins R; Ward ME; Hao L
    Mol Neurodegener; 2023 Nov; 18(1):87. PubMed ID: 37974165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progranulin null mutations in both sporadic and familial frontotemporal dementia.
    Le Ber I; van der Zee J; Hannequin D; Gijselinck I; Campion D; Puel M; Laquerrière A; De Pooter T; Camuzat A; Van den Broeck M; Dubois B; Sellal F; Lacomblez L; Vercelletto M; Thomas-Antérion C; Michel BF; Golfier V; Didic M; Salachas F; Duyckaerts C; Cruts M; Verpillat P; Van Broeckhoven C; Brice A;
    Hum Mutat; 2007 Sep; 28(9):846-55. PubMed ID: 17436289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient mice.
    Tanaka Y; Matsuwaki T; Yamanouchi K; Nishihara M
    Neuroscience; 2013 Feb; 231():49-60. PubMed ID: 23201826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses.
    Tapia L; Milnerwood A; Guo A; Mills F; Yoshida E; Vasuta C; Mackenzie IR; Raymond L; Cynader M; Jia W; Bamji SX
    J Neurosci; 2011 Aug; 31(31):11126-32. PubMed ID: 21813674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of exosomes in progranulin-associated frontotemporal dementia.
    Benussi L; Ciani M; Tonoli E; Morbin M; Palamara L; Albani D; Fusco F; Forloni G; Glionna M; Baco M; Paterlini A; Fostinelli S; Santini B; Galbiati E; Gagni P; Cretich M; Binetti G; Tagliavini F; Prosperi D; Chiari M; Ghidoni R
    Neurobiol Aging; 2016 Apr; 40():41-49. PubMed ID: 26973102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia.
    Aswathy PM; Jairani PS; Raghavan SK; Verghese J; Gopala S; Srinivas P; Mathuranath PS
    Neurobiol Aging; 2016 Mar; 39():218.e1-3. PubMed ID: 26724960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury.
    Menzel L; Kleber L; Friedrich C; Hummel R; Dangel L; Winter J; Schmitz K; Tegeder I; Schäfer MK
    Glia; 2017 Feb; 65(2):278-292. PubMed ID: 27778404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.